Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings

F. Horak, Jr., M. Alexander, H. L. Graham, F. Peter, B. Siobhain, W. Kaye, P. Hilary, B. Elisabeth, S. M. Stephen (Perth, Australia; Vienna, Austria; Zurich, Switzerland)

Source: Annual Congress 2004 - Clinical questions being answered by paediatric lung function
Session: Clinical questions being answered by paediatric lung function
Session type: Thematic Poster Session
Number: 1024
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Horak, Jr., M. Alexander, H. L. Graham, F. Peter, B. Siobhain, W. Kaye, P. Hilary, B. Elisabeth, S. M. Stephen (Perth, Australia; Vienna, Austria; Zurich, Switzerland). Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings. Eur Respir J 2004; 24: Suppl. 48, 1024

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults
Source: Eur Respir J 2007; 30: 769-781
Year: 2007



Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 369s
Year: 2006

Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Noninvasive assessment of airway inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164
Year: 2003

Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010


Diagnostic value of induced sputum and nitric oxide in exhaled breath condensate to control treatment of bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 503s
Year: 2006

Markers of fibrosis in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) in sarcoidosis
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008

Extended exhaled nitric oxide measurements at different exhalation flows may differentiate between bronchial airways and alveolar inflammation in patients with asthma and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
Year: 2002

Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004

Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

Markers of inflammation in exhaled breath condensate and bronchoalveolar lavage fluid
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007


Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003

Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma
Source: Eur Respir J 2002; 20: 1393-1398
Year: 2002



Exhaled nitric oxide (eNO) and acidity of exhaled breath condensate (EBC pH) of children with asthma, cystic fibrosis (CF) and healthy controls
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005

Sputum inflammatory biomarkers and exhaled nitric oxide (FENO) in varying severity asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Nasal lavage cysteinyl-leukotrienes correlate with exhaled breath condensate in children
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006

Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004